Immune cell profiling and antibody responses in patients with COVID-19

被引:16
|
作者
Rezaei, Mitra [1 ]
Mahmoudi, Shima [2 ]
Mortaz, Esmaeil [3 ]
Marjani, Majid [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Virol Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Childrens Med Ctr Hosp, Pediat Ctr Excellence, Pediat Infect Dis Res Ctr, Dr Gharib St,Keshavarz Blvd, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran
关键词
SARS-CoV-2; COVID-19; Antibody response; Lymphocyte subsets;
D O I
10.1186/s12879-021-06278-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundAlthough there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses.MethodsIn this cross-sectional study, the levels of peripheral lymphocyte subsets were measured using flow cytometry in 53 patients with positive SARS-CoV-2 RT-PCR, for whom antibody testing of COVID-19 was performed.ResultsThe white blood cell, neutrophil, and lymphocyte counts consistently decreased in the IgM and IgG non-responder group, while the differences in the median value between the two study groups were found to be statistically significant only in terms of neutrophil counts (P=0.024 for IgM response and p-value= 0.046 for IgG response, respectively). Moreover, the level of neutrophil-to-lymphocyte ratio was observed to be significantly lower in the IgM or IgG non-responder group compared to the IgM or IgG responder group (3.63.1 vs. 6.3 +/- 4.2; p-value= 0.021). The patients with IgM antibody response had a significantly lower CD20(+) lymphocytes (11% versus 15% in the groups without IgM antibody response, p-value= 0.031), The percentages of NK cells and CD4(+) T cells significantly increased in the patients with IgG antibody response compared to those without IgG antibody response (13% versus 10%, p-value= 0.028, and 41.5% versus 34%; p-value= 0.03, respectively). Moreover, the patients who produced IgM or IgG antibody had significantly higher percentages of total T lymphocytes (64% versus 54%; p-value= 0.017), CD4(+) T cells (41% versus 34%; p-value=0.038), and NK cells (13% versus 9%, p-value=0.023) compared to the group with no serological response. No significant difference was observed in the percentage of other lymphocyte subsets, including CD8(+) T cells, T-reg cells, and CD19(+) B cells.Conclusion Our results suggest that the total T cells, CD4(+) T cells, and NK cells percentages are linked to serological response. Moreover, our findings suggested that neutrophil absolute counts and neutrophil-to-lymphocyte ratio may be valuable predictors of IgM or IgG antibody response.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Immune cell profiling and antibody responses in patients with COVID-19
    Mitra Rezaei
    Shima Mahmoudi
    Esmaeil Mortaz
    Majid Marjani
    BMC Infectious Diseases, 21
  • [2] Antibody responses in COVID-19 patients
    Liu, Shuying
    Lu, Shan
    JOURNAL OF BIOMEDICAL RESEARCH, 2020, 34 (06): : 410 - 415
  • [3] Antibody responses in COVID-19 patients
    Shuying Liu
    Shan Lu
    The Journal of Biomedical Research, 2020, 34 (06) : 410 - 415
  • [4] Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
    Ehmsen, Sidse
    Asmussen, Anders
    Jeppesen, Stefan S.
    Nilsson, Anna Christine
    Osterlev, Sabina
    Vestergaard, Hanne
    Justesen, Ulrik S.
    Johansen, Isik S.
    Frederiksen, Henrik
    Ditzel, Henrik J.
    CANCER CELL, 2021, 39 (08) : 1034 - 1036
  • [5] Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
    Li, Fang
    Luo, Meng
    Zhou, Wenyang
    Li, Jinliang
    Jin, Xiyun
    Xu, Zhaochun
    Juan, Liran
    Zhang, Zheng
    Li, Yuou
    Liu, Renqiang
    Li, Yiqun
    Xu, Chang
    Ma, Kexin
    Cao, Huimin
    Wang, Jingwei
    Wang, Pingping
    Bu, Zhigao
    Jiang, Qinghua
    PROTEIN & CELL, 2021, 12 (10) : 751 - 755
  • [6] Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
    Fang Li
    Meng Luo
    Wenyang Zhou
    Jinliang Li
    Xiyun Jin
    Zhaochun Xu
    Liran Juan
    Zheng Zhang
    Yuou Li
    Renqiang Liu
    Yiqun Li
    Chang Xu
    Kexin Ma
    Huimin Cao
    Jingwei Wang
    Pingping Wang
    Zhigao Bu
    Qinghua Jiang
    Protein & Cell, 2021, 12 (10) : 751 - 755
  • [7] Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19
    Bi, Xiaojie
    Liu, Wei
    Ding, Xuan
    Liang, Shuang
    Zheng, Yufen
    Zhu, Xiaoli
    Quan, Sheng
    Yi, Xiao
    Xiang, Nan
    Du, Juping
    Lyu, Haiyan
    Yu, Die
    Zhang, Chao
    Xu, Luang
    Ge, Weigang
    Zhan, Xinke
    He, Jiale
    Xiong, Zi
    Zhang, Shun
    Li, Yanchang
    Xu, Ping
    Zhu, Guangjun
    Wang, Donglian
    Zhu, Hongguo
    Chen, Shiyong
    Li, Jun
    Zhao, Haihong
    Zhu, Yi
    Liu, Huafen
    Xu, Jiaqin
    Shen, Bo
    Guo, Tiannan
    CELL REPORTS, 2022, 38 (03):
  • [8] Immune Responses in Patients with COVID-19: An Overview
    Kamat, Deepak
    Kamat, Aarti
    Mathur, Ambika
    PEDIATRIC ANNALS, 2021, 50 (05): : E222 - E226
  • [9] Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy
    Nguyen, Thi H. O.
    Lim, Chhay
    Lasica, Masa
    Whitechurch, Ashley
    Tennakoon, Surekha
    Saunders, Natalie R.
    Allen, Lilith F.
    Rowntree, Louise C.
    Chua, Brendon Y.
    Kedzierski, Lukasz
    Tan, Hyon-Xhi
    Wheatley, Adam K.
    Kent, Stephen J.
    Karapanagiotidis, Theo
    Nicholson, Suellen
    Williamson, Deborah A.
    Slavin, Monica A.
    Tam, Constantine S.
    Kedzierska, Katherine
    Teh, Benjamin W.
    EJHAEM, 2023, 4 (01): : 216 - 220
  • [10] Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
    Garanina, Ekaterina
    Hamza, Shaimaa
    Stott-Marshall, Robert J.
    Martynova, Ekaterina
    Markelova, Maria
    Davidyuk, Yuriy
    Shakirova, Venera
    Kaushal, Neha
    Baranwal, Manoj
    Khaertynova, Ilsiyar M.
    Rizvanov, Albert
    Foster, Toshana L.
    Khaiboullina, Svetlana
    FRONTIERS IN MICROBIOLOGY, 2022, 13